Endpoints Livestream: Is the biotech market really as bad as it seems?
Today on Post-Hoc Live, we’re going to take a deep dive into Founding Editor John Carroll’s Endpoints 100 survey. Twice a year for almost a decade, John has sent a long list ...
Today on Post-Hoc Live, we’re going to take a deep dive into Founding Editor John Carroll’s Endpoints 100 survey. Twice a year for almost a decade, John has sent a long list ...
